By Anthony O. Goriainoff AstraZeneca said Friday that its Alexion division will buy a portfolio of preclinical rare-disease gene therapies from Pfizer for up...
In the burgeoning web3 industry, crypto-startup Launchpad XYZ is carving a unique niche. Not content to merely offer trading services, the company is bolstering...